Sylva, Inc.

NEW YORK, NY · Founded 2020 · CIK 0001865077 · Medtech

A genetic biobank platform that collects and analyzes genetic and health data from participants to identify precision medicine matches for heart disease

sylva.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$23M
3 Form D · Apr 2023
42 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,654,983
Private capital raisedForm D · SEC$12,525,000
Private capital raisedForm D · SEC$5,670,995
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1433Piezobiomembrane, Inc.——
1434Unique Mobility Devices LLC——
1435Sigil, Inc.—$1.1M
1436Sylva, Inc.—$23M
1437OnPoint Spine, Inc.——
1438Eli Technologies, Inc.—$6.8M
1439VERIFAX CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Adam AgenskyDirector
  • Thomas GuthrieDirector · Executive Officer
  • Kyle HarrisonDirector
  • Ameet ShahDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.